Aberrant methylation and down-regulation of TMS1/ASC in human glioblastoma

American Journal of Pathology

Volumn 165, Issue 4, 2004, Pages 1151-1161

  Stone, Annalisa R ^a   Bobo, William ^a   Brat, Daniel J ^a   Devi, Nara S ^a   Van Meir, Erwin G ^a   Vertino, Paula M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METHYLTRANSFERASE INHIBITOR;

ADULT; AGED; APOPTOSIS; ARTICLE; ASTROCYTE; ASTROCYTOMA; CANCER CELL CULTURE; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; CYTOKINE PRODUCTION; DEMETHYLATION; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE LOCUS; GENE SILENCING; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN INDUCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SURVIVAL RATE; TARGET OF METHYLATION ASSOCIATED SILENCING 1 GENE;

EID: 4644314826     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63376-7     Document Type: Article

References (40)

1. Fine HA: The basis for current treatment recommendations for malignant gliomas. J Neurooncol 1994, 20:111-120
2. Kleihues P, Burger PC, Scheithauer BW: The new WHO classification of brain tumours. Brain Pathol 1993, 3:255-268
3. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P: Grading of astrocytomas. A simple and reproducible method. Cancer 1988, 62:2152-2165
4. Hunter SB, Brat DJ, Olson JJ, Von Deimling A, Zhou W, Van Meir EG: Alterations in molecular pathways of diffusely infiltrating glial neoplasms: application to tumor classification and anti-tumor therapy, Int J Oncol 2003, 23:857-869
5. Baylin SB, Herman JG: DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000, 16:168-174
6. Jones PA, Baylin SB: The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002, 3:415-428
7. Costello JF, Plass C: Methylation matters. J Med Genet 2001, 38:285-303
8. Bird AP: CpG-rich islands and the function of DNA methylation. Nature 1986, 321:209-213
9. Bird AP, Wolffe AP: Methylation-induced repression-belts, braces, and chromatin. Cell 1999, 99:451-454
10. Costello JF: DNA methylation in brain development and gliomagenesis. Front Biosci 2003, 8:s175-s184
11. Costello JF, Plass C, Cavenee WK: Aberrant methylation of genes in low-grade astrocytomas. Brain Tumor Pathol 2000, 17:49-56
12. Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, Baylin SB, Herman JG: Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 2000, 343:1350-1354
13. Balana C, Ramirez JL, Taron M, Roussos Y, Ariza A, Ballester R, Sarries C, Mendez P, Sanchez JJ, Rosell R: O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)- 1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme. Clin Cancer Res 2003, 9:1461-1468
14. Komine C, Watanabe T, Katayama Y, Yoshino A, Yokoyama T, Fukushima T: Promoter hypermethylation of the DNA repair gene O6-methylguanine-DNA methyltransferase is an independent predictor of shortened progression free survival in patients with low-grade diffuse astrocytomas. Brain Pathol 2003, 13:176-184
15. Conway KE, McConnell BB, Bowring CE, Donald CD, Warren ST, Vertino PM: TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers. Cancer Res 2000, 60:6236-6242
16. Masumoto J, Taniguchi S, Ayukawa K, Sarvotham H, Kishino T, Niikawa N, Hidaka E, Katsuyama T, Higuchi T, Sagara J: ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells. J Biol Chem 1999, 274:33835-33838
17. McConnell BB, Vertino PM: TMS1/ASC: the cancer connection. Apoptosis 2004, 9:5-25
18. Srinivasula SM, Poyet JL, Razmara M, Datta P, Zhang Z, Alnemri ES: The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J Biol Chem 2002, 277:21119-21122
19. Martinon F, Burns K, Tschopp J: The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002, 10:417-426
20. Stehlik C, Lee SH, Dorfleutner A, Stassinopoulos A, Sagara J, Reed JC: Apoptosis-associated speck-like protein containing a caspase recruitment domain is a regulator of procaspase-1 activation. J Immunol 2003, 171:6154-6163
21. Stehlik C, Fiorentino L, Dorfleutner A, Bruey JM, Ariza EM, Sagara J, Reed JC: The PAAD/PYRIN-family protein ASC is a dual regulator of a conserved step in nuclear factor kappaB activation pathways. J Exp Med 2002, 196:1605-1615
22. Ishii N, Maier D, Merlo A, Tada M, Sawamura Y, Diserens AC, Van Meir EG: Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol 1999, 9:469-479
23. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996, 93:9821-9826
24. Xiong Z, Laird PW: COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res 1997, 25:2532-2534
25. Levine JJ, Stimson-Crider KM, Vertino PM: Effects of methylation on expression of TMS1/ASC in human breast cancer cells. Oncogene 2003, 22:3475-3488
26. Kleihues P, Burger PC, Collins VP, Newcomb EW, Ohgaki H, Cavenee WK: Glioblastoma. Pathology and Genetics: Tumours of the Nervous System. Edited by P Kleihues, WK Cavenee. Lyon, International Agency for Cancer Res, 1997, pp 29-39
27. Moriai R, Tsuji N, Kobayashi D, Yagihashi A, Namiki Y, Takahashi H, Watanabe N: A proapoptotic caspase recruitment domain protein gene, TMS1, is hypermethylated in human breast and gastric cancers. Anticancer Res 2002, 22:4163-4168
28. Virmani A, Rathi A, Sugio K, Sathyanarayana UG, Toyooka S, Kischel FC, Tonk V, Padar A, Takahashi T, Roth JA, Euhus DM, Minna JD, Gazdar AF: Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer. Int J Cancer 2003, 106:198-204
29. Masumoto J, Taniguchi S, Nakayama J, Shiohara M, Hidaka E, Katsuyama T, Murase S, Sagara J: Expression of apoptosis-associated speck-like protein containing a caspase recruitment domain, a pyrin N-terminal homology domain-containing protein, in normal human tissues. J Histochem Cytochem 2001, 49:1269-1275
30. Guan X, Sagara J, Yokoyama T, Koganehira Y, Oguchi M, Saida T, Taniguchi S: ASC/TMS1, a caspase-1 activating adaptor, is down-regulated by aberrant methylation in human melanoma. Int J Cancer 2003, 107:202-208
31. Shiohara M, Taniguchi S, Masumoto J, Yasui K, Koike K, Komiyama A, Sagara J: ASC, which is composed of a PYD and a CARD, is up-regulated by inflammation and apoptosis in human neutrophils. Biochem Biophys Res Commun 2002, 293:1314-1318
32. Heard E, Rougeulle C, Arnaud D, Avner P, Allis CD, Spector DL: Methylation of histone H3 at Lys-9 is an early mark on the X chromosome during X inactivation. Cell 2001, 107:727-738
33. Bachman KE, Park BH, Rhee I, Rajagopalan H, Herman JG, Baylin SB, Kinzler KW, Vogelstein B: Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell 2003, 3:89-95
34. Stimson KM, Vertino PM: Methylation-mediated silencing of TMS1/ASC is accompanied by histone hypoacetylation and CpG island-localized changes in chromatin architecture. J Biol Chem 2002, 277:4951-4958
35. Yokoyama T, Sagara J, Guan X, Masumoto J, Takeoka M, Komiyama Y, Miyata K, Higuchi K, Taniguchi S: Methylation of ASC/TMS1, a proapoptotic gene responsible for activating procaspase-1, in human colorectal cancer. Cancer Lett 2003, 202:101-108
36. Kito T, Kuroda E, Yokota A, Yamashita U: Cytotoxicity in glioma cells due to interleukin-12 and interleukin-18-stimulated macrophages mediated by interferon-gamma-regulated nitric oxide. J Neurosurg 2003, 98:385-392
37. Kikuchi T, Akasaki Y, Joki T, Abe T, Kurimoto M, Ohno T: Antitumor activity of interleukin-18 on mouse glioma cells. J Immunother 2000, 23:184-189
38. Conti B, Park LC, Calingasan NY, Kim Y, Kim H, Bae Y, Gibson GE, Joh TH: Cultures of astrocytes and microglia express interleukin 18. Brain Res Mol Brain Res 1999, 67:46-52
39. Chauvet N, Palin K, Verrier D, Poole S, Dantzer R, Lestage J: Rat microglial cells secrete predominantly the precursor of interleukin-1beta in response to lipopolysaccharide. Eur J Neurosci 2001, 14:609-617
40. Cuny E, Loiseau H, Penchet G, Ellie E, Arsaut J, Vital A, Vincendeau P, Demotes-Mainard J: Association of elevated glial expression of interleukin-1beta with improved survival in patients with glioblastomas multiforme. J Neurosurg 2002, 96:294-301